AI Drug Discovery companies

Achira develops atomistic foundation simulation models combining machine learning and physics-based methods to advance drug discovery.

Absentia Labs builds AI foundation models from biological and clinical data to predict drug behavior and accelerate pharmaceutical development.

Matterworks, Inc. builds AI-powered tools for extracting insights from biological data to support therapeutic discovery, drug development, and biomanufacturing.